Science 37: sourced choices
6 product and go-to-market choices, oldest first. Back to the case study
- 2021-12-31Product · Platform and services Science 37 sold platform access and trial delivery services. SC1
- 2021-12-31Product · Delivery network Mobile clinicians and investigators supported decentralized visits. SC1
- 2021-12-31Go_To_Market · Customer concentration PPD accounted for 22.9% of 2021 revenue. SC1
- 2022-12-31Product · Contract termination Many contracts allowed termination without cause with short notice. SC2
- 2022-12-31Go_To_Market · Cancellations Reported cancellation rate increased to 36.9% in 2022. SC2
- 2024-03-12Go_To_Market · Acquisition eMed completed a cash acquisition at $5.75 per share. SC4